- Home
- E vs A Comparison
E vs A Comparison
Compare E & A Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- E
- A
- Stock Information
- Founded
- E 1953
- A 1999
- Country
- E Italy
- A United States
- Employees
- E N/A
- A N/A
- Industry
- E Oil & Gas Production
- A Biotechnology: Laboratory Analytical Instruments
- Sector
- E Energy
- A Industrials
- Exchange
- E Nasdaq
- A Nasdaq
- Market Cap
- E 42.6B
- A 40.2B
- IPO Year
- E 1995
- A 1999
- Fundamental
- Price
- E $26.38
- A $134.51
- Analyst Decision
- E Buy
- A Buy
- Analyst Count
- E 6
- A 15
- Target Price
- E $39.60
- A $141.93
- AVG Volume (30 Days)
- E 331.3K
- A 2.0M
- Earning Date
- E 02-14-2025
- A 11-25-2024
- Dividend Yield
- E 8.24%
- A 0.70%
- EPS Growth
- E N/A
- A 5.73
- EPS
- E 0.85
- A 4.43
- Revenue
- E $102,822,886,419.00
- A $6,510,000,000.00
- Revenue This Year
- E N/A
- A $7.13
- Revenue Next Year
- E N/A
- A $6.45
- P/E Ratio
- E $15.18
- A $30.36
- Revenue Growth
- E N/A
- A N/A
- 52 Week Low
- E $26.12
- A $124.16
- 52 Week High
- E $34.30
- A $155.35
- Technical
- Relative Strength Index (RSI)
- E 22.75
- A 44.65
- Support Level
- E $28.10
- A $131.62
- Resistance Level
- E $27.06
- A $144.90
- Average True Range (ATR)
- E 0.34
- A 3.13
- MACD
- E -0.12
- A -0.76
- Stochastic Oscillator
- E 10.07
- A 21.76
About E ENI S.p.A.
Eni is an integrated oil and gas company that explores for, produces, and refines oil around the world. In 2023, the company produced 0.8 million barrels of liquids and 4.6 billion cubic feet of natural gas per day. At end-2023, Eni held reserves of 6.4 billion barrels of oil equivalent, 48% of which are liquids. The Italian government owns a 30.1% stake in the company. Eni is placing its renewable and low-carbon business in a separate entity called Plentitude, which it will likely list publicly at some point.
About A Agilent Technologies Inc.
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life science and diagnostic firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools, cross lab consisting of consumables and services related to life science and applied tools, and diagnostics and genomics. Over half of its sales are generated from the biopharmaceutical, chemical, and advanced materials end markets, which we view as the stickiest end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the US and China representing the largest country concentrations.